Delivery Order SPE2DB20D3304-SPE2DB24FW7D7

Award Date 8/28/24
Potential Completion Date 8/29/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of M-M-R II (measles, mumps, and rubella) vaccine vials. The contract has a firm fixed-price of $1,537.14 and an ultimate completion date of August 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II (measles, mumps, and rubella) vaccine vials. The $22,723.12 firm-fixed-price contract has an ultimate completion date of August 29, 2024. This award is under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which enables the efficient procurement of...
This is a $26,643.76 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of M-M-R II vaccine vials. The contract has an ultimate completion date of July 19, 2024 and does not utilize a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II vaccine vials. The contract has a ceiling value of $25,002.36 and an ultimate completion date of November 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
This is a $7,319.57 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for M-M-R II vaccine vials. The order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, which runs through November...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of M-M-R II vaccine vials. The contract is a firm fixed-price delivery order with a ceiling value of $1,574.46 and a completion date of September 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a...
This is a $2,543.68 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II VACCINE VIALS. The delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 with DLA Troop Support Medical for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. There is no set-aside designation for this...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II (Measles, Mumps, and Rubella) vaccine vials. The contract has a ceiling value of $10,496.40 and a completion date of September 20, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of M-M-R II vaccine vials. The delivery order, valued at $3,165.80, was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of M-M-R II vaccine vials. The contract has a ceiling value of $14,510.94 and a completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB24FW7D7
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II (measles, mumps, and rubella) vaccine vials. The award has a firm fixed price of $3,156.27 and an ultimate completion date of August 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the government to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals and vaccines, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/27/24, 9:20 AM